What Advanced Solutions does

Advanced Solutions, Inc. (ASI) is a privately held holding company founded in 1987 and headquartered in Louisville, Kentucky, with engineering and research operations in Manchester, New Hampshire. It operates five active subsidiaries spanning biomedical instrumentation (Advanced Solutions Life Sciences, focused on the BioAssemblyBot 6-axis robotic 3D bioprinting platform for human tissue), AI/ML R&D (Innovation Labs), educational AI products (Power of Public Speaking), warehouse workflow software (Slot3D), and self-service kiosk software (Xpedient). The founder-led company employs 101-250 people and sells directly via phone and web to academic, enterprise, and industrial customers across multiple US-based verticals.

The company's core proprietary technology is the BioAssemblyBot, a six-axis robotic 3D bioprinter used to fabricate human tissue structures, supported by an intellectual property portfolio of 13 registered trademarks and a 2017 YPO Global Innovation Award. Beyond Life Sciences, the company has a multi-decade history in CAD/CAM software distribution and Autodesk reselling, the latter of which was divested to Rand Worldwide in February 2019 to refocus on proprietary IP and software. Adjacent capabilities include machine-learning cell-analysis pipelines housed in Innovation Labs and an educational AI product line acquired via Pops Classroom.

ASI generates revenue through a mix of capital-equipment sales (bioprinters), consumables and recurring service contracts (Life Sciences), and software licensing across its commercial and educational subsidiaries. Go-to-market is direct via phone and web, with no disclosed external pricing or enterprise logo disclosures. The company has not raised disclosed outside capital and is funded internally, operating as a US-only entity with growth concentrated in the structurally expanding 3D bioprinting end-market.

Name

Advanced Solutions

Legal name

Advanced Solutions, Inc.

Website

https://corporate.advancedsolutions.com

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

101–250 employees

Short description

Advanced Solutions is a privately held holding company operating five subsidiaries, anchored by Advanced Solutions Life Sciences and its proprietary BioAssemblyBot 6-axis robotic 3D bioprinting platform for human tissue, serving biomedical, industrial, and educational customers via direct US sales.

Ownership category

akta.pro rank

Product category

3D Bioprinting & Tissue Engineering Technology

NAICS

Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Surgical Appliance and Supplies Manufacturing (339113), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Computer Systems Design Services (541512)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

Healthcare & Assistive Robotics (HDAAAIAC)

akta.pro secondary industries

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), AI/ML Engineering & Model Development Services (BPAEAHAF), AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs) (HDAEANAJ)

Keywords

• 3D bioprinting systems
• Tissue engineering software
• Warehouse workflow visualization
• Self-serve kiosk applications
• AI machine learning platforms

Headquarters

HQ city

Louisville

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Technology Solutions & Software Products: ASI generates revenue through diversified technology subsidiaries providing integrated hardware and software solutions. The company serves multiple industries including biomedical, life sciences, manufacturing, and retail through products like 3D bioprinters, AI solutions, workflow automation software, and kiosk applications.
2. Engineering Services & Consulting: The company provides software customization and automation services to industries, leveraging deep subject matter expertise in biomedical, material handling, artificial intelligence, software development, and retail sectors.
3. Product Sales (3D Bioprinting Systems): Sale of BioAssemblyBot® and related bioprinting hardware systems and accessories for biomedical and pharmaceutical applications.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Advanced Solutions, Inc. is a diversified technology holding company that designs, develops, and sells integrated hardware and software solutions through wholly owned subsidiaries. Its flagship offering is the BioAssemblyBot 6-axis robotic 3D bioprinting system paired with TSIM simulation software for biomedical and pharmaceutical tissue engineering, complemented by AI/ML products (Innovation Labs), warehouse workflow visualization software (Slot3D), self-serve kiosk applications (Xpedient), and speech preparation tools (Power of Public Speaking).

Product overview

ASI (Advanced Solutions, Inc.) is a diversified technology company offering an integrated portfolio of hardware and software solutions across five subsidiary brands. The core product is BioAssemblyBot, a 6-Axis Robotic 3D Printing System for human tissue structures, used in the life sciences subsidiary. Additional subsidiaries include Innovation Labs (AI/ML products), Power of Public Speaking (presentation tools), Slot3D (warehouse workflow visualization), and Xpedient (kiosk application software). These products serve biomedical, life sciences, material handling, manufacturing, artificial intelligence, academic, retail, and software industries.

Differentiator

Problem solved

Functional benefit

Brands

• Advanced Solutions Life Sciences: Innovative 3D bio-printing technology for the biomedical and pharmaceutical industries
• Innovation Labs
• Power of Public Speaking
• Slot3D
• Xpedient

Products and services

• BioAssemblyBot A 6-Axis Robotic 3D Printing System for Human Tissue Structures that uses six degrees of freedom movement to fabricate complex human tissue and potentially organs. It is the lead invention by CEO Michael Golway and is paired with TSIM simulation software for biomedical and pharmaceutical tissue engineering applications.
• TSIM (Tissue Structure Simulation and Modeling) Software for controlling and managing the BioAssemblyBot 6-axis robotic 3D bioprinting system, used to design, simulate, and model tissue structures prior to fabrication. Targeted at biomedical and pharmaceutical researchers building tissue engineering workflows.
• Slot3D Software products that help companies visualize, simulate, and analyze warehouse workflows to streamline operations and reduce operating costs. Targeted at manufacturing, material handling, and logistics enterprises seeking workflow optimization.
• Xpedient Software for businesses to create, manage, and deploy self-serve kiosk applications. Targeted at retail and business service clients needing customer self-service and operational automation.
• Innovation Labs AI/ML Products Industry-focused AI/Machine Learning products, services, and solutions. Targeted at academic, technology, and enterprise clients seeking AI integration, automation, and intelligent systems development, including machine-learning-driven cell analysis for 3D bioprinted tissues.
• Power of Public Speaking Products designed to prepare, practice, present, and review better speeches. Targeted at academic institutions and professionals seeking communication training tools and improved presentation confidence.
• Vascularized In Vitro Perfusion Module (VIPM) In vitro perfusion technology module for tissue vascularization, used in Advanced Solutions Life Sciences bioprinting workflows to support vascularized tissue engineering and drug research applications.

Quantifiable outcome

• European 3D bioprinting market growing from $0.75B (2024) to $2.14B by 2033 at 12.35% CAGR

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature10 records

Scale indicators4 records

Recent moves11 records

Expansion highlights5 records

Broad incumbents

• Stratasys: Stratasys is a broad incumbent in 3D printing with healthcare and dental applications alongside its core industrial business. Comparable as a 3D printing platform company with healthcare exposure, though its PolyJet and FDM technology differs from ASI's robotic 6-axis bioprinting approach.
• 3D Systems Corporation: 3D Systems is a broad incumbent in 3D printing, with a healthcare-focused division offering 3D-printed surgical planning models, prosthetics, and bioprinting research. Comparable as an established 3D printing platform that has moved into healthcare-adjacent applications, though its core business is industrial 3D printing rather than tissue engineering.
• Intuitive Surgical: Intuitive Surgical is the dominant medical robotics incumbent (da Vinci surgical systems). Comparable as an established player in healthcare robotics, providing a benchmark for the type of platform economics ASI's BioAssemblyBot may eventually target if robotic tissue engineering transitions to clinical applications.
• Thermo Fisher Scientific: Thermo Fisher is a broad incumbent in life sciences tools, including laboratory equipment and reagents used by the same pharmaceutical and academic customers ASI serves. Comparable as an established supplier to the same research end-market, and represents a potential acquirer or channel partner for ASI's bioprinting business.

Direct peers

• Materialise NV: Materialise provides 3D printing software and services for medical and industrial applications, including personalized surgical planning and medical device manufacturing. Comparable to ASI as a 3D printing-enabled healthcare solutions provider, though Materialise focuses on software/services rather than bioprinting hardware.
• Organovo Holdings: Organovo is a direct peer in 3D bioprinting for human tissue, focused on developing functional human tissues for medical research and therapeutic applications. Directly comparable as both companies target pharmaceutical and academic customers seeking bioprinted tissue models, though Organovo is publicly listed and has raised substantial external capital versus ASI's privately-held structure.
• Aspect Biosystems: Aspect Biosystems is a direct peer developing bioprinted tissue therapeutics using a microfluidic 3D bioprinting platform. Comparable to ASI Life Sciences in targeting pharmaceutical research customers with bioprinting technology, though Aspect has established major pharmaceutical partnerships (e.g., with Novo Nordisk) that ASI lacks.
• BICO (formerly CELLINK): BICO is a direct bioprinting peer offering bioprinters, bioinks, and laboratory services for tissue engineering and regenerative medicine. Comparable to ASI Life Sciences as both sell 3D bioprinting hardware and consumables to research customers, though BICO has a broader product portfolio and significant external capital backing.

Emerging players

• Allevi (now part of 3D Systems): Allevi (acquired by 3D Systems) is an emerging bioprinting peer offering desktop bioprinters and bioinks for research applications. Comparable as a bioprinting hardware vendor targeting academic and pharmaceutical labs, though at a smaller scale and with extrusion-based rather than 6-axis robotic printing.
• Poietis: Poietis is an emerging player in laser-assisted 3D bioprinting for tissue engineering and regenerative medicine. Comparable as a niche bioprinting technology company targeting pharmaceutical research customers, with a different (laser-based) technical approach than ASI's robotic extrusion-based BioAssemblyBot.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/getasi1

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advanced Solutions